1 Pan Z Y. Clinical nuclear medicine. Beijing: AtomicEnergy Press, 1994, 549–551.2 Kwilas A R, Donahue R N, Bernstein M B, et al. FrontOncol, 2012, 2: 104–106.3 Sharkey R M, Goldenberg D M. J Nucl Med, 2005, 1:115–127.4 Yu L, Ju D W, Chen W, et al. Cancer Biother Radiopharm,2006, 21: 5–14.5 Bayés M, Rabasseda X, Prous J R. Methods Find Exp ClinPharmacol, 2005, 27: 711–738.6 Like Y, Dian W J, Chen W P, et al. Cancer Biother Radio,2006, 21: 7–14.7 Hilary H S, Michael L G, George A F, et al. CancerBiother Radio, 2006, 21: 243–256.8 Alia H, Andrew S. Future Oncol, 2012, 8: 659-669.9 Pan H, Niu G Q, Pan J, et al. Acta Pharm Sinica, 2006, 41:506–512.10 Eisenhauer E A, Therasse P, Bogaerts J, et al. Eur J Cancer,2009, 45: 228–247.11 Kaczmarek L, Calabretta B, Baserga R. Proc Natl AcadSci, 1985, 82: 5375–5379.12 Pelz A F, Müller G, Wieacker P. Cancer Genet Cytogenet,2005, 157: 157–159.13 F. Mitelman ed. S. Karger, Basel. ISCN, 1995.14 Ma Q J, Gao S, Zhao J. Nucl Sci Tech, 2008, 19: 230–235.15 Higashi T, Nishii R, Yamada S. J Nucl Med, 2011, 52:683–689.16 Carter P. Nat Rev Cancer, 2001, 1: 118–129.17 Goldenberg D M. J Nucl Med, 2002, 43: 693–713.18 Milenic D E. Curr Pharm Des, 2002, 8: 1749–1764.19 Ross J S, Gray K, Gray G S, et al. Am J Clin Pathol, 2003,119: 472–485.20 Chen S L, Yu L K, Jiang C Y, et al. J Clin Oncol, 2005, 23:1538–1547.21 Patel S J, Shapiro W R, Laske D W, et al. Neurosurgery,2005, 56: 1243–1253.22 William R S, Susan P C, Roberts K, et al. Expert OpinBiol Ther, 2006, 6: 539–545.23 Chang W P, Tsai M S, Hwang J S, et al. Mutat Res, 1999,16, 428: 99–105.24 Hartford S A, Luo Y, Southard T L, et al. Proc Natl AcadSci U S A, 2011, 108: 17702–17707. |